Biologics Bottlenecks Pt 3: Transition to Better Biologics Production

How Continuous Biomanufacturing Can Transform Biologics Production

Quality Hits at Lightning Speed – Hit Identification at Evotec

Mitochondrial Toxicity (Seahorse) Fact Sheet

Evotec Immuno-Oncology Services: From Target Identification to Clinical Trials

Laboratory Cold Storage - The Enemy of the Environment

Hit Identification / High-Throughput Screening Factsheet

Innovative Technologies to Dramatically Expand Global Access to Biotherapeutics

Chapter One - Harnessing Conformational Drivers in Drug Design

No Compromise! Combining Quality, Flexibility and Reliability With the New JFM Integration for the CyBio Well vario

Leveraging Sample Management Strengths to Support Biologics Research

BraMosA: Our New Smartcel-2 Boosting Serial Dilution Preparation

Cyprotex Sample Management – Supporting Our Future

Setting up Biological Storage Capabilities in Sample Management, Evotec Toulouse

Evotec’s Basic Performance Verification Processes for DMSO Based Liquid Handlers

Transferring Evotec’s Screening Library to AcoustiX Tubes: State-Of-The-Art Technology at the Service of Increased Efficiency and Reduced Compound Consumption

Up-To-Date Technology and Optimized Organization for Sample Management

Up-To-Date Technology and Optimized Organization for Sample Management

Transferring Evotec’s Screening Library to AcoustiX Tubes: State-Of-The-Art Technology at the Service of Increased Efficiency and Reduced Compound Consumption

Evotec’s Basic Performance Verification Processes for DMSO Based Liquid Handlers

Setting up Biological Storage Capabilities in Sample Management, Evotec Toulouse

Cyprotex Sample Management – Supporting Our Future

BraMosA: Our New Smartcel-2 Boosting Serial Dilution Preparation

Leveraging Sample Management Strengths to Support Biologics Research

No Compromise! Combining Quality, Flexibility and Reliability With the New JFM Integration for the CyBio Well vario

Sample Management: Enhancing Project Value with Our Services

AI-Based Antibody Discovery Platform Identifies Therapeutic mAbs Against Multiple SARS-CoV-2 Strains

Diverse Modalities Fact Sheet

Matrix Binding Fact Sheet

Just – Evotec Biologics opens biomanufacturing facility - J.POD® Toulouse, France (EU)

Physicochemical Profiling Fact Sheet

Why to choose Continuous Biomanufacturing over Fed-batch

How Just-Evotec Biologics’ J.MD Molecular Design Service Helps Derisk CMC Efforts

Cardiotoxicity Risk Assessment using AI/ML and In Vitro Assays

In Vitro Permeability Fact Sheet

The Power of Harnessing the Immune System: Immuno-Oncology as a Game Changer in Cancer Treatment

The Cost Efficiency of Continuous Biomanufacturing for First-in-Human Biopharmaceutical Supply

Regulatory Insights for Converting Batch to Continuous Biomanufacturing Processes

Biologics Bottlenecks Pt 2: Benefits of Continuous Manufacturing

Transporter Inhibition Fact Sheet

Transporter Substrate ID Fact Sheet

Drug-drug Interaction (DDI) Fact Sheet

Non Regulatory Bioanalysis Fact Sheet

Metabolite Profiling and Identification Fact Sheet

Drug-Induced Liver Injury Fact Sheet

Cardiotoxicity Fact Sheet

Cell Painting Fact Sheet

Material Science: Solid Form Matters!

PXR, AhR & CAR3 Nuclear Receptor Activation Fact Sheet

High Throughput ADME Fact Sheet

Microsomal Stability Fact Sheet

Precision In Every Breath: Evotec’s Holistic Inhalation Drug Product Design And Development

Biologics Bottlenecks Pt 1: Limitations of Conventional Manufacturing

Why Choose Continuous Over Very Large-Scale Drug Substance Manufacturing?

From Academic Concept to Commercial Reality: How to Accelerate Translational Drug Discovery

From Development to Delivery: How Continuous Manufacturing is Redefining the Commercial Landscape for Biologics

Innovations in Oligonucleotide Synthesis for RNA-Targeted Drug Discovery

Transitioning to ICH M12 - Know the Facts!

Strategies to Improve Quality and Agility when Producing Monoclonal Antibody Biotherapeutics

Immune-Shielded and Safe iPSC-derived Cardiomyocytes for Heart Repair

Overcoming some of the Pitfalls of Retinal Organoid (RO) Culturing: Towards Large Scale Production

New Translational Screening Assay with Phenotypic and Transcriptomic Readouts using hiPSC-derived Organoids from a Nephrotic Syndrome Patient

ICH M12 2024 vs Japanese PMDA 2018 DDI Guidelines. Navigating the Changes.

Comparison of ICH M12 with Japanese PMDA DDI Guideline

ICH M12 2024 vs EMA 2013 DDI Guidance. What’s New?

Comparison of ICH M12 with EMA DDI Guideline

Unlocking the Future of Drug Discovery & Development with Evotec’s Clinical Proteomics

Green Chemistry at Evotec: Pioneering Sustainable Drug Discovery

Advancing Immunotherapy through Immunopeptidome Deciphering for Neoantigen Identification

2024 ICH M12 Guideline Comparison with 2020 FDA Guidance

Turning the Crank using a Hybrid Continuous Purification Platform

Watch on Demand Webinar - Assessing Transporter DDI Risk During Drug Discovery and Development

DoE Approach Applied to (TSWG) Platform: A Case Study

It All Starts With a Protein – Protein Sciences as a Key to Success in Drug Discovery

Quality Risk Management

Application of Design of Experiments in API Chemical Development

Rescuing the Unsolvable – A Case Study

Conversion of Fed-Batch to Continuous Bioprocess

Molecular Interactions Matter - Biophysical Screening for Early Drug Discovery

Involving clinicians in model-based designs with Non-DLT Adverse Events Integration: A safer approach to increase the performance of dose-escalation Phase I cancer trials

ICH M12 2024 vs FDA 2020 DDI Guidance - Exploring the Differences

Commercial Active Pharmaceutical Ingredient manufacturing challenges

Biomanufacturing cost reduction

Conversion of a Fed-Batch Process to a Continuous Bioprocess

Metabolic Characterization of a Perfusion Bioprocess

A High Productivity CHO Expression System for the Continuous Manufacturing of Antibodies” On-Demand Webinar

Continuous Biomanufacturing Arrives in Europe

Key considerations for API process development and optimization

OncoResponse chose Just-Evotec Biologics for the Phase 1 clinical manufacturing of their cancer-fighting antibody

Clinical proteomics: A focus on Bodyfluids

Tackling Autoimmune Disease with CAR iNK Cells

Achieving Continuous Manufacturing through Equipment Design

The Downstream Data Browser

The New ICH M12 Guideline – Harmony at Last for DDI Studies!

Delay with product Shelf-Life estimation? We can do it ASAP!

Real Life Evaluations of the User of Acoustic Tubers Under Normal Operations in a Compound Management Department

Leveraging Evotec Sample Management’s expertise and versatility for efficient integrated Research Projects: from compound acquisition to biological insights

Small molecule modulation of RNA splicing for drugging “undruggable” targets: taking advantage of Evotec’s high-throughput RT-qPCR platform

Combination of Affinity Selection Mass Spectrometry with Biophysical approaches to identify and characterize biomolecules binders

Development of a BRET assay for high throughput screening of Transcription Factor – DNA interaction modulators

Streamlining Hit Finding: Evotec's Integrated Approach to Sample Management and Hit ID

Continuous Biomanufacturing Reduces Environmental Impact

Fighting Tuberculosis by Targeting the Essential Enzyme 4’-Phosphopantetheinyl Transferase (PptT)

Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents

Redirecting Raltitrexed from Cancer Cell Thymidylate Synthesis to Mycobacterium Tuberculosis

Navigating IBD with Evotec: From discovery to cure

Crystal structure of human peptidylarginine deiminase type VI (PAD6) provides insights into its inactivity

Navigating IBD with Evotec - From Discovery to Cure

J.CHO High Expression System for Continuous Manufacturing with Extraordinary Titers

Antifungal Drug Discovery Fact Sheet

Evotec Drug Discovery for ID

SARS-CoV2 2024

Hollow Fibre Infection Model 2024

Tuberculosis Capabilities 2024

Unlocking the Potential of Biomarkers: Enhancing Drug Development and Clinical Practice with a Focus on Aging

Addressing unmet challenges in CAR T cell therapeutics

Combatting solid tumours with iPSC-derived macrophage (iMAC) cell therapy

Unveiling Drug Targets with Precision: Leveraging Quantitative Proteomics

Functional Genomics for an enhanced Anti-Infective pipeline 2024

Anti-Fungal Capabilities 2024

AMR Capabilities 2024

Advances in Cardiotoxicity Prediction using Transcriptomics and Machine Learning

Find out Fast! Improved Efficiency in Endocrine Disrupter Screening of Chemicals

Establishing a New High Throughput Endocrine Disruptor Screening Panel

Development of a SP-TFF Step for Continuous End-to-End mAb Bioprocessing

New Early Stage Genotoxicity Screening Approach for Food Additives

New Genotoxicity Pre-screening Package for Food Additives

Drug Discovery Chemistry - Leveraging AI/ML DMTA engine

Proteomics and Metabolomics

Toxicogenomics and AI: A Breakthrough in DILI Prediction

Toxicogenomics and AI: A Breakthrough in DILI Prediction

Immuno-Oncology Therapeutic Area

Just - Evotec Biologics Introduction March 2024

Evotec DNA Damage Response

Evotec In vivo / Ex vivo Oncology and IO 2024

Evotec PanHunter Flyer

Oncology EVT801

Oncology Biomarkers 2024

Oncology iR&D 2024

Achieving Fully Continuous Downstream

J.POD® Toulouse: Revolutionizing Biologics Manufacturing in Europe

Continuous Biomanufacturing in Agile Production Facilities

How To Optimize Your Hit Identification Strategy – Evotec

ACS BIOT

Automated Patched Clamp Electrophysiology: Intracellular Exchange Assay

Implementation of SplintR ligation qPCR as novel bioanalytical method for tissues quantification of oligonucleotide therapeutics for the expansion of the Evotec oligonucleotide drug discovery platform

Webinar Slides: Deciphering the Clinical DDI Between Atazanavir and Rosuvastatin

Pipeline Co-creation Overview

Protein Science Solutions for Drug Discovery Overview

Data Driven Solutions for Drug Discovery - Protein Sciences

Hit and Lead ID Capabilities Presentation

Biotech's Rise in Externalization of Compound Management Service Whitepapers

Evotec (US) Sample Management Whitepaper

CRISPR Platform for Target Identification & Validation at Evotec Poster

Evotec (US) Sample Management Poster

RNA Epitranscriptomics as a Novel Therapeutic Target - Evotec and STORM Therapeutics Developing a METTL3 Inhibitor

BMWS 2024

American College of Toxicology (ACT)

Bio-Europe 2024

Integrated and Continuous Biomanufacturing (ICB) Conference

SLAS 2024 Sample Management Symposium

CPHI Milan

European Biomanufacturing Summit 2024

EUROTox 2024

ISSCR Annual Meeting 2024

JSOT (The 51st Annual Meeting of the Japanese Society of Toxicology)

Mining Omics Data for Drug Discovery

Deciphering the Immunopeptidome for Neoantigen Identification

Quantitative Proteomics for Target Deconvolution and Selectivity Profiling

Global Bioprocessing & Pharma 4.0 Summit

BioMed Israel

Pharma Manufacturing World Summit

A Candidate Antibody Drug for Prevention of Malaria

Virtual Roundtable on Continuous Manufacturing

Challenges in Biomanufacturing

Convergence Forum 2024

BioKorea 2024

London Biotechnology Show

34th ECCMID

35th Medicinal Chemistry in Eastern England

Science 2 Start Up

AACR Annual Meeting 2024

A Candidate Antibody Drug for Prevention of Malaria

A DoE Approach to Study the Influence of TSWG Process Parameters on the Characteristics of Granules and Tablets

Characterization of Compression Behavior of Co-Processed Excipient for Production of Orally Dispersable Tablets and of their Blends with Active Ingredient

A Study to Assess the Gastro-Resistance and Dissolution Rate of Enteric Coated Not-Banded Gelatin and HPMC Capsules

Impact of Tooling Size on the Heckel Profile and Derived Compressibility Parameters

Better and faster prediction of your drug product’s stability

Aerodynamic Particle Size Distribution

Presenting at BioProcess Int. Europe 2024

Presenting at BPI US West 2024

Virtual Roundtable Continuous Manufacturing

63rd SOT Annual Meeting and ToxExpo 2024

Bio-Europe Spring 2024

SLAS 2024

ADME/DMPK Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practice

American Biomanufacturing Summit 2024

Challenges in Biomanufacturing and How Just-Evotec Biologics Plans to Overcome Them

Optimizing Continuous Biomanufacturing Parameters Minimizes Costs

DCAT Week